(Q42167256)

17 October 2017

title

Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy (English)

1 reference

17 October 2017

6

Ulf-Håkan Stenman

1 reference

17 October 2017

Anneli Lauhio

1

1 reference

17 October 2017

Timo Sorsa

2

1 reference

17 October 2017

Ravi Srinivas

3

1 reference

17 October 2017

Mathias Stenman

4

1 reference

17 October 2017

Taina Tervahartiala

5

1 reference

17 October 2017

Carola Grönhagen-Riska

7

1 reference

17 October 2017

Eero Honkanen

8

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

17 October 2017

1 reference

17 October 2017

volume

40

1 reference

17 October 2017

issue

4

1 reference

17 October 2017

page(s)

312-320

1 reference

New functions for the matrix metalloproteinases in cancer progression

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Activation of type IV procollagenases by human tumor-associated trypsin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

The role of matrix metalloproteinases in the activation of mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Activation of matrix metalloproteinase-8 by membrane type 1-MMP and their expression in human tears after photorefractive keratectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Tumor-Associated Trypsinogen-2 (Trypsinogen-2) Activates Procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Renal replacement therapy in patients with diabetes and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Matrix metalloproteinases (MMPs) in oral diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Doxycycline: a pilot study to reduce diabetic proteinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Doxycycline decreases proteinuria in glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Chronic kidney disease: the global challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801923746

10.1080/07853890801923746

21 January 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference